Background: Basaloid squamous cell carcinoma (BSCC) is a rare subtype of squamous cell carcinoma with a high rate of distant metastasis. BSCC occurs most commonly in the esophagus, lungs, and head and neck. However, BSCC occurring in an atypical site without a known primary tumor and/or with the presence of atypical immunohistochemical features can result in delayed diagnosis or misdiagnosis. Case presentation: Here, we report a case of a 67-year-old man with liver metastatic BSCC with negative pancytokeratin (AE1/AE3) expression. He presented with a chief complaint of epigastric discomfort. Imaging examination revealed a subcapsular mass in the right anterior lobe of the liver. Then, the patient underwent an irregular right hepatectomy. Grossly, the mass was gray, with a size of 7 × 7 × 4 cm. Microscopically, the mass comprised epithelioid tumor cells with both solid and pseudoadenoid structures, accompanied by necrosis. Immunohistochemical staining showed that the tumor cells were negative for AE1/AE3, CK18, CK7, CK19, Hepatocyte Paraffin-1, Glypican-3, Arginase-1, CD56, Chromogranin A, Synaptophysin, Vimentin, and Carcinoembryonic antigen. The Ki-67 index was 80%.The mass was diagnosed as a malignant tumor but could not be classified further. One month after surgery, the patient's reexamination revealed esophageal tumor, and biopsy revealed BSCC. The slides of the liver tumor were reviewed, and the morphology was similar to that of the esophageal tumor. Moreover, supplementary immunohistochemical staining of liver tumor indicated p63 and p40 were strongly positive, that confirmed the liver tumor was metastatic BSCC. Previous studies have reported that 3.7% of esophageal BSCCs did not express AE1/AE3. Conclusion: When a malignant tumor comprises epithelioid cells with solid and/or pseudoadenoid structures, but not adenocarcinoma or neuroendocrine carcinoma, even if the tumor cells are negative or weakly positive for AE1/ AE3, we should consider BSCC. For a definite diagnosis, immunohistochemical staining for squamous cell carcinoma markers, including p63 and p40, and examination of common primary sites of BSCC should be performed.
Background
Basaloid squamous cell carcinoma (BSCC) is a rare and special subtype of squamous cell carcinoma. BSCC usually occurs in older men and most commonly in the esophagus, lungs, and head and neck. The diagnosis of BSCC mainly depends on its histological morphological features [1] [2] [3] . It has been never reported there is primary BSCC in the liver. However, there are certain cases in which BSCC of the liver is found first, and then the primary tumor is found or arduous to discover [4] . BSCC could present a pseudoadenoid pattern, and the immunohistochemical markers of squamous cell carcinoma, which include p63, p40 and CK5/6, could serve to confirm the diagnosis. BSCC has shown high positivity for pancytokeratin (AE1/AE3), but in rare cases, this expression is absent [5, 6] . When epithelioid malignancy in the liver or other sites presents a pseudoadenoid structure, especially with AE1/AE3 negative expression, the possibility of metastatic BSCC may be rarely considered without a history of primary cancer, which results in delayed diagnosis or misdiagnosis. Here, we report a case of liver metastatic BSCC with negative expression of AE1/AE3 and reviewed the relevant literature.
Case presentation
A 67-year-old man presented to our hospital with the chief complaint of epigastric discomfort for a few months. There was no history of hepatitis or tumor. Magnetic resonance imaging (MRI) of the liver showed solitary hepatic space-occupying lesions with a size of approximately 5.2 × 4.2 cm, mainly located under the capsule of the right liver V and VI segments. Abdominal ultrasonography revealed a heterogeneous echogenic mass in the right lobe of the liver, which was 7.5 × 9.3 cm in size and located under the liver capsule. There was no imaging examination other than the normal frontal and lateral chest examinations. Then, the patient underwent irregular resection of the right liver, and a hilar lymph node dissection was performed. During the operation, there were no ascites, and the liver was dark red without obvious cirrhosis.
Grossly, the mass was 7 × 7 × 4 cm in size. The mass was fragile and gray. Histopathological examination revealed that the tumor was composed of monotonous epithelioid cells (Fig. 1a) , which were closely arranged with solid and pseudoadenoid structures (Fig. 1b and c) . Tumorous necrosis was obvious (Fig. 1d) . The tumor cells were round or ovoid, with hyperchromatic nuclei, scant basophilic cytoplasm, and increased mitotic activity ( Fig. 1e and Fig. 1f ). Immunohistochemical staining showed that the tumor cells were negative for AE1/AE3 (Fig. 1g) , CK18 (Fig. 1h) , CK7 (Fig. 1i) , Hepatocyte Paraffin-1(Hep Par-1) (Fig. 1j ), Glypican-3 (GPC-3), Arginase-1 (ARG-1), CD56 (Fig. 1k ), Chromogranin A (CgA), Synaptophysin (Syn), Vimentin, and Carcinoembryonic antigen (CEA). The Ki-67 index was 80% (Fig. 1l ). Due to atypical histological morphology and immunohistochemical characteristics, the mass was diagnosed as a malignant tumor but could not be classified further.
One month after surgery, the patient underwent computed tomography (CT) scan, which revealed that the middle thoracic esophageal wall was thickening. Endoscopic examination showed an esophageal tumor, and ). e and f The tumor cells were round or ovoid, with hyperchromatic nuclei, scant basophilic cytoplasm, and increased mitotic activity (H&E, 400×). Immunohistochemical staining showed that the tumor cells were negative for AE1/AE3 (g), CK18 (h), CK7 (i), Hep Par-1 (j), and CD56 (k). The Ki-67 index was 80% (l) (40×) biopsy revealed BSCC ( Fig. 2a and b) . The esophageal tumor cells were weakly reactive to AE1/AE3 (Fig. 2c) and strongly reactive to CK5/6, p40 and p63. Then, slides of the liver tumor were reviewed, and the morphology was similar to that of an esophageal tumor. Moreover, supplementary immunohistochemistry staining of the liver tumor, including CK5/6, p40 and p63, was performed. The liver tumor cells were weakly reactive to CK5/6 (Fig. 2d) and diffusely positive for p40 (Fig. 2e)  and p63 (Fig. 2f) , which proved that the liver tumor was metastatic BSCC.
The patient died in 3 months after conservative treatment without further surgical treatment, radiotherapy or chemotherapy because he was in poor physical condition.
Discussion
BSCC is prone to distant metastasis. The common organs of distant metastasis include the lungs, liver and bone [1, 6] . The histological morphology mainly included (1) multiple invasive growth modes, such as solid, lobular, cribriform, pseudoadenoid, trabecular, etc., accompanied by central comedonecrosis; (2) tumor cells with hyperchromatic nuclei, scant basophilic cytoplasm, and increased mitotic activity; (3) palisade tumor cells surrounding the nests; (4) basement membrane-like substances between the cells; and (5) with or without common squamous cell carcinoma components. BSCC is usually positive for immunohistochemical staining of epithelial markers, including AE1/AE3, CK5/6, CK14, CK34βE12, p63 and p40. A few cases showed the weak expression of neuroendocrine markers. A portion of the BSCC of the head and neck and BSCC of the anus are associated with human papillomavirus (HPV) infection, and p16 is positive [2, 5, [7] [8] [9] [10] . However, BSCCs of esophagus have shown zero positivity rates for HPV DNA, as assessed in situ hybridization (ISH) [11] .
The diagnosis of BSCC is mainly based on its histological morphology, so we should be familiar with its morphology features. However, it is difficult to consider the diagnosis of metastatic tumors, if without known primary BSCC history. The primary tumor may be occult. Bastiaan DBW et al. [4] reported a case of liver BSCC with characteristic histological morphology. The patient died of extensive abdominal and pelvic metastasis without a primary lesion found in 2 years, and no autopsy was performed after death. The authors suggested that although no other primary tumor has been diagnosed, it is not possible to prove that this is a primary liver tumor without autopsy to rule out occult malignancies elsewhere. The case we reported herein had no known primary tumor before surgery. Unfortunately, we did not diagnosed as metastatic BSCC until the primary esophageal tumor was found by chance. In fact, the morphology of the liver tumor was typical BSCC. Thus, clinical physical examination, imaging examination and endoscopic examination are necessary to rule out metastatic tumors from other sites.
The confusion in this case resulted from the fact that the expression of cytokeratin, including AE1/AE3, CK18 and CK7, was negative in the metastatic site. This finding led us to diagnose this case as a malignant tumor, but not a carcinoma. Thus, the pertinent literature was reviewed. No studies on the immunohistochemical staining of AE1/ AE3 in metastatic BSCC and no negative results were reported. However, in the study of primary BSCCs, 108 esophageal BSCCs with AE1/AE3 immunohistochemical staining were reviewed. Four were negative, with a negative rate of 3.7% [6, [12] [13] [14] [15] [16] [17] (Table 1) . And negative AE1/ AE3 expression was also found in BSCC of head and neck [18] . In addition to the negative expression of AE1/AE3, there are also cases in which CK5/6 is not expressed in BSCC. Patil DT et al. [19] reported that 3 of 15 cases were negative for CK5/6 in BSCC of the anal canal. Cho k et al. [20] reported that 9 out of 26 patients with BSCC of the head and neck did not express CK5/6. However, there is no literature reporting that BSCC lacks the expression of p40 and p63, which may be more effective markers for BSCC.
Conclusion
Pathologists should be well aware of the histological and morphological features of BSCC. In the uncommon locations of BSCC, where the malignant tumor is composed of epithelioid cells with solid and/or pseudoadenoid structures, but not adenocarcinoma or neuroendocrine carcinoma, even if the tumor cells are negative or weakly positive for pancytokeratin, we should consider BSCC. For a definite diagnosis, immunohistochemical staining for squamous cell carcinoma markers and the examination of common primary sites of BSCC should be performed. In this case, the primary lesion was weakly positive for AE1/AE3, while the metastatic lesion was negative
